DNB Fund - Biotechnology C1 CHF (Acc) header image

DNB Fund - Biotechnology C1 CHF (Acc)

Fund

ISIN LU2814038696 / Valor 13492064

NAV (2026-04-09)
CHF 116.84+1.41%

DNB Fund - Biotechnology C1 CHF (Acc)
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

DNB Fund – Biotechnology focuses on investing in the stocks of large to medium-sized companies within the biotechnology, diagnostics, pharmaceuticals, biomedicine, gene therapy, and other healthcare-related sectors. Managed with a fundamental investment approach, the fund seeks long-term positive returns by selecting firms that adhere to strong governance practices. It maintains geographic flexibility, allowing it to choose the best opportunities from global markets to build a diverse and specialized portfolio in the healthcare and biotech industries.

Content summarized by AI chatbot
Tags:
healthcare biotechnology nasdaq biotechnology index

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

OTHER SHARE CLASSES OF THIS FUND

DNB Fund - Biotechnology N CHF (Acc)
DNB Fund - Biotechnology N CHF (Acc) DNB Fund - Biotechnology N CHF (Acc) Valor: 13492065
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.41%CHF 116.55
DNB Fund - Biotechnology A EUR (Acc)
DNB Fund - Biotechnology A EUR (Acc) DNB Fund - Biotechnology A EUR (Acc) Valor: 13492590
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.25%EUR 121.11
DNB Fund - Biotechnology N EUR (Acc)
DNB Fund - Biotechnology N EUR (Acc) DNB Fund - Biotechnology N EUR (Acc) Valor: 13491841
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.25%EUR 122.45
DNB Fund - Biotechnology C1 EUR (Acc)
DNB Fund - Biotechnology C1 EUR (Acc) DNB Fund - Biotechnology C1 EUR (Acc) Valor: 13491849
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.25%EUR 122.75